Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Altman Insider Profile
4 Followers
Peter Altman, President & CEO, Director at BioCardia, holds 39.24K shares in BioCardia (Ticker: BCDA). Most recently, Peter Altman Bought $500 shares of BioCardia on Jun 24, 2024 for an estimated value of 1.65K.
Peter Altman BioCardia (BCDA)President & CEO, Director
BioCardia (BCDA)
President & CEO, Director
Ranked #95,323 out of 98,042 Corporate Insiders
Profitable Transactions
7 out of 41 Profitable Transactions
Average Return
-33.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Peter Altman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Altman
Peter Altman's Trading History
List of latest transactions for each holding click on a transaction to see Peter Altman's performance on stock
You May Also Like
Peter Altman insider profile FAQ
What is the percentage of profitable transactions made by Peter Altman?
The percentage of profitable transactions made by Peter Altman is 17%.
What is the average return per transaction made by Peter Altman?
The average return per transaction made by Peter Altman is -33.90%.
What stocks does Peter Altman hold?
Peter Altman holds: BCDA stocks.
What was Peter Altman’s latest transaction?
Peter Altman latest transaction was an Informative Buy of $1.65K.
What was Peter Altman's most profitable transaction?
Peter Altman’s most profitable transaction was an Informative Buy of BCDA stock on June 13, 2022. The return on the trade was 57.80%.
What is Peter Altman's role in BioCardia?
Peter Altman's role in BioCardia is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.